SFR

(2R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-5-[(2R)-oxolan-2-yl]-2,3-dihydro-1,3-thiazole-4-carboxylic acid

Created:	2007-11-27
Last modified:	2024-09-27

Find Related PDB Entry
2 entries where SFR is found as a standalone ligand2 entries where SFR is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	4
Bond Count	38
Aromatic Bond Count	0

2D diagram of SFR

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2R)-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-5-[(2R)-oxolan-2-yl]-2,3-dihydro-1,3-thiazole-4-carboxylic acid
Synonyms	FAROPENEM, unbound, hydrolyzed form
Systematic Name (OpenEye OEToolkits)	(2~{R})-2-[(2~{S},3~{R})-1,3-bis(oxidanyl)-1-oxidanylidene-butan-2-yl]-5-[(2~{R})-oxolan-2-yl]-2,3-dihydro-1,3-thiazole-4-carboxylic acid
Formula	C₁₂ H₁₇ N O₆ S
Molecular Weight	303.331
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OC(=O)C(C1NC(C(O)=O)=C(S1)C2OCCC2)C(O)C
SMILES	CACTVS	3.385	C[CH](O)[CH]([CH]1NC(=C(S1)[CH]2CCCO2)C(O)=O)C(O)=O
SMILES	OpenEye OEToolkits	2.0.6	CC(C(C1NC(=C(S1)C2CCCO2)C(=O)O)C(=O)O)O
Canonical SMILES	CACTVS	3.385	C[C@@H](O)[C@H]([C@@H]1NC(=C(S1)[C@H]2CCCO2)C(O)=O)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.6	C[C@H]([C@H]([C@@H]1NC(=C(S1)[C@H]2CCCO2)C(=O)O)C(=O)O)O
InChI	InChI	1.03	InChI=1S/C12H17NO6S/c1-5(14)7(11(15)16)10-13-8(12(17)18)9(20-10)6-3-2-4-19-6/h5-7,10,13-14H,2-4H2,1H3,(H,15,16)(H,17,18)/t5-,6-,7-,10-/m1/s1
InChIKey	InChI	1.03	CGJDLFMMMJEANA-DAGMQNCNSA-N

Related Resource References

Resource Name	Reference
PubChem	23627205

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.